Schaff DL et al., Cell Genomics - Schaff et al. use multi-treatment clonal tracing combined with single-cell RNA-seq to show that rare, pre-existing transcriptional states in melanoma predict resistance to diverse therapies and that high CD44 marks cells with multi-treatment tolerance. Key terms: melanoma, CD44, clonal tracing, scRNA-seq, drug resistance.
Study Highlights:
Using high-throughput lentiviral barcoding across six distinct treatments, the authors show that rare melanoma clones can develop resistance to multiple unrelated therapies. Clonal resistance is heritable over roughly six doublings and top resistant clones overlap across treatment pairs. High pre-treatment CD44 expression marks cells that are more likely to resist dabrafenib, trametinib, and hypoxia-mimetic stress, and CD44-high cells show elevated lysosomal activity. Pre-treatment transcriptional programs map to divergent resistant end states, revealing multiple paths to resistance.
Conclusion:
Pre-existing, heritable transcriptional cell states—including a CD44-high program with elevated lysosomal activity—can predict and underlie multi-treatment resistance in melanoma, and mapping these states can expose distinct routes to treatment failure.
Music:
Enjoy the music based on this article at the end of the episode.
Article title:
Pre-existing cell states predict resistance to multiple treatments
First author:
Schaff DL
Journal:
Cell Genomics
DOI:
10.1016/j.xgen.2026.101191
Reference:
Schaff DL, White PE, Cote CJ, et al. Pre-existing cell states predict resistance to multiple treatments. Cell Genomics. 2026;6:101191. doi:10.1016/j.xgen.2026.101191
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
More at basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/pre-existing-cell-states-predict-resistance
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2026-07-22.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the core narrative on six-treatment clonal resistance, CD44/FN1 markers, lysosomal mechanism, and CNMF/cNMF-based mapping from pre-treatment states to resistance end-states, plus validation and limitations described in the transcript.
- transcript topics: Six-treatment panel design and outcomes in WM989 melanoma cells; Barcoding and clonal tracing methodology; Pre-treatment gene expression states as predictors of resistance; CD44 and FN1 as markers of multi-treatment resistance; lysosomal sequestration mechanism; CNMF/cNMF analysis linking initial states to resistant end states; Differentiated vs mesenchymal initial states and divergent resistance pathways
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- Six-treatment panel including two targeted inhibitors (dabrafenib, trametinib), two stressors (CoCl2, acid...
Chapters
- (00:00:20) - What Really Happens to Cancer Resistance?
- (00:06:15) - The melanoma'specialists'
- (00:12:37) - Melanoma cell survival: Multiple paths to survival
- (00:19:04) - Black Skin Cancer: The blueprint for its generalist resistance
- (00:21:38) - Oh It's Built Before the Battle
